Skye Bioscience, Common Stock Investor Sentiment
| SKYE Stock | USD 2.85 0.01 0.35% |
About 67% of Skye Bioscience,'s investor base is looking to short. The analysis of the overall investor sentiment regarding Skye Bioscience, Common suggests that many traders are alarmed. The current market sentiment, together with Skye Bioscience,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Skye Bioscience, Common stock news signals to limit their universe of possible portfolio assets.
Skye |
Skye Bioscience, Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Skye Bioscience, can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Skye Bioscience, that are available to investors today. That information is available publicly through Skye media outlets and privately through word of mouth or via Skye internal channels. However, regardless of the origin, that massive amount of Skye data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Skye Bioscience, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Skye Bioscience, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Skye Bioscience,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Skye Bioscience, alpha.
Skye Bioscience, Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Jenkins Annalisa of 70000 shares of Skye Bioscience, at 5.15 subject to Rule 16b-3 | 10/28/2024 |
2 | Acquisition by Dhillon Punit of 110000 shares of Skye Bioscience, at 0.0171 subject to Rule 16b-3 | 11/01/2024 |
3 | Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights | 11/07/2024 |
4 | Skye Bioscience Surpasses 50 percent Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor | 11/14/2024 |
5 | Disposition of 307 shares by Grayson Paul A. of Skye Bioscience, at 5.55 subject to Rule 16b-3 | 11/15/2024 |
6 | Disposition of 86244 shares by Grayson Paul A. of Skye Bioscience, at 4.99 subject to Rule 16b-3 | 11/18/2024 |
7 | Skye Bioscience chief development officer sells shares worth 97,721 | 11/20/2024 |
8 | British Design Firm Forecasts 2025 Color Trends | 11/21/2024 |
9 | Callous coward Finlay MacDonald jailed for life after murdering his brother-in-law | 11/29/2024 |
10 | Insider Trading | 12/09/2024 |
11 | Skye Bioscience to Present at J.P. Morgan Healthcare Conference | 12/19/2024 |
Complementary Tools for Skye Stock analysis
When running Skye Bioscience,'s price analysis, check to measure Skye Bioscience,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Skye Bioscience, is operating at the current time. Most of Skye Bioscience,'s value examination focuses on studying past and present price action to predict the probability of Skye Bioscience,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Skye Bioscience,'s price. Additionally, you may evaluate how the addition of Skye Bioscience, to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |